Glenmark Life Sciences Q2 PAT rises 11% to Rs 119 crore

Glenmark Life Sciences Q2 Results: Glenmark Life Sciences said its profit after tax rose 11 per cent year-on-year to Rs 119 crore for the second quarter ended September 30, 2023.

Glenmark Life Sciences Q2 PAT rises 11% to Rs 119 crore
Revenue from operations increased to Rs 595 crore during the quarter, a year-on-year growth of 17 per cent, Glenmark Life Sciences said in a regulatory filing. Pic: glenmarklifesciences.com

Glenmark Life Sciences Q2 Results: Glenmark Life Sciences on Friday said its profit after tax rose 11 per cent year-on-year to Rs 119 crore for the second quarter ended September 30, 2023.

Revenue from operations increased to Rs 595 crore during the quarter, a year-on-year growth of 17 per cent, Glenmark Life Sciences said in a regulatory filing.

"Geographically, regulated markets including the US, Europe, LATAM and India continue to spearhead our growth," Glenmark Life Sciences MD and CEO Yasir Rawjee said.

LATAM refers to Latin American countries.

Looking ahead, enhanced visibility towards the H2 FY24 demand for generic API and CDMO business bolsters the company's confidence in delivering growth in FY24, he added.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.   

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-mutual-fund-sip-retirement-corpus-planning-calculator-how-soon-can-monthly-investment-of-rs-6000-8000-and-10000-reach-inr-50000000-market-linked-return-328118

Power of Compounding: How soon will monthly SIP of Rs 6,000, Rs 8,000, and Rs 10,000 reach Rs 5 crore corpus target?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-guaranteed-return-scheme-know-much-maturity-amount-you-will-get-on-rs-2-lakh-25-lakh-3-lakh-35-lakh-and-rs-4-lakh-investments-under-amrit-vrishti-fd-scheme-state-bank-of-india-fixed-deposits-326837

SBI Guaranteed Return Scheme: Know how much maturity amount you will get on Rs 2 lakh, 2.5 lakh, 3 lakh, 3.5 lakh and Rs 4 lakh investments under Amrit Vrishti FD scheme

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-senior-citizen-fd-rate-currently-know-what-state-bank-of-india-providing-in-1-year-3-year-5-year-fixed-deposits-latest-returns-on-term-deposits-by-public-lender-savings-scheme-327750

SBI Senior Citizen FD Rate: Here's what State Bank of India giving on 1-year, 3-year, 5-year fixed deposits currently

https://www.zeebiz.com/markets/ipo/news-ntpc-green-energy-parent-psu-ntpc-how-to-check-ipo-allotment-status-328117

NTPC Green Energy IPO: How to check allotment status online

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-senior-citizen-fd-latest-fixed-deposit-interest-rates-calculator-what-investors-can-get-on-inr-700000-1400000-2100000-investments-in-amrit-vrishti-1-3-and-5-year-guaranteed-return-schemes-327822

SBI Senior Citizen Latest FD Rates: What senior citizens can get on Rs 7 lakh, Rs 14 lakh, and Rs 21 lakh investments in Amrit Vrishti, 1-, 3-, and 5-year fixed deposits

https://www.zeebiz.com/personal-finance/photo-gallery-sipswp-for-retirement-planning-corpus-calculator-inr-rs-10000-monthly-sip-and-inr-2500000-lump-sum-investment-and-then-rs-215000-monthly-income-for-25-years-calculations-327783

SIP+SWP: Rs 10,000 monthly SIP for 20 years, Rs 25 lakh lump sum investment, then Rs 2.15 lakh monthly income for 25 years; see expert calculations

https://www.zeebiz.com/personal-finance/photo-gallery-sip-investment-vs-ppf-comparison-build-corpus-15-years-investing-rs-15-lakh-calculations-327911

SIP vs PPF: How much corpus you can build in 15 years by investing Rs 1.5 lakh per year? Understand through calculations

Written By: PTI
Updated: Fri, Oct 20, 2023
06:34 PM IST
PTI
RELATED NEWS
Glenmark Life Sciences Q3 results: Net profit rises 13% at Rs 119 crore Glenmark Life Sciences Q3 results: Net profit rises 13% at Rs 119 crore
1,150% dividend: This pharma stock to trade ex-date on Tuesday 1,150% dividend: This pharma stock to trade ex-date on Tuesday
Glenmark Life Sciences announces interim dividend for FY24 Glenmark Life Sciences announces interim dividend for FY24
Glenmark Life Sciences board to consider Q2 results, dividend on this date Glenmark Life Sciences board to consider Q2 results, dividend on this date
Glenmark Pharma share jumps over 6% as S&P Global upgrades rating from 'stable' to 'positive' Glenmark Pharma share jumps over 6% as S&P Global upgrades rating from 'stable' to 'positive'

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x